Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Marcelin · SciRah

Researcher profile · Semantic Scholar

A. Marcelin

Share profile

A. Marcelin — researcher profile on SciRah

h-index: 63
Works: 511
Citations: 14K

Most-cited papers

Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial
A. Monsel, C. Hauw-Berlemont, M. Mebarki, N. Heming +38 more
2022Critical Care93 citations Open access
Semantic Scholar
Viral suppression and HIV-1 drug resistance 1 year after pragmatic transitioning to dolutegravir first-line therapy in Malawi: a prospective cohort study.
B. Schramm, E. Temfack, D. Descamps, S. Nicholas +11 more
2022The Lancet HIV76 citations Open access
Semantic Scholar
Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals
Mathieu Hubert, F. Guivel-Benhassine, T. Bruel, F. Porrot +26 more
2023medRxiv63 citations Open access
Semantic Scholar
Phenotypic Heterogeneity of Fulminant COVID-19--Related Myocarditis in Adults
P. Barhoum, M. Pineton de Chambrun, K. Dorgham, M. Kerneis +23 more
2022Journal of the American College of Cardiology41 citations Open access
Semantic Scholar
Spike Gene Evolution and Immune Escape Mutations in Patients with Mild or Moderate Forms of COVID-19 and Treated with Monoclonal Antibodies Therapies
A. Jary, S. Marot, A. Fayçal, S. Leon +12 more
2022Viruses34 citations Open access
Semantic Scholar
Transmitted drug resistance to integrase based first-line HIV antiretroviral regimens in the Mediterranean Europe.
Adolfo de Salazar, L. Viñuela, A. Fuentes, E. Teyssou +19 more
2022Clinical Infectious Diseases33 citations
Semantic Scholar
Virological efficacy of switch to DTG plus 3TC in a retrospective observational cohort of suppressed HIV-1 patients with or without past M184V - The LAMRES Study.
M. Santoro, D. Armenia, E. Teyssou, J. R. Santos +10 more
2022Journal of Global Antimicrobial Resistance31 citations Open access
Semantic Scholar
Epidemiology and Characteristics of SARS-CoV-2 Variants of Concern: The Impacts of the Spike Mutations
T. Cochérie, K. Zafilaza, V. Leducq, S. Marot +3 more
2022Microorganisms30 citations Open access
Semantic Scholar
Decreased Sensitivity of Rapid Antigen Test Is Associated with a Lower Viral Load of Omicron than Delta SARS-CoV-2 Variant
T. Cochérie, Mathilda Bastide, Soraya Sakhi, K. Zafilaza +8 more
2022Microbiology spectrum27 citations Open access
Semantic Scholar
HIV DNA Sequencing to Detect Archived Antiretroviral Drug Resistance
A. Geretti, J. Blanco, A. Marcelin, C. Perno +3 more
2022Infectious Disease and Therapy26 citations Open access
Semantic Scholar
Mutations in the 3'-PPT Lead to HIV-1 Replication without Integration
C. Richetta, F. Subra, I. Malet, H. Leh +10 more
2022Journal of Virology25 citations Open access
Semantic Scholar
Impact of Anti PD-1 Immunotherapy on HIV Reservoir and Anti-Viral Immune Responses in People Living with HIV and Cancer
M. Baron, C. Soulié, A. Lavolé, L. Assoumou +17 more
2022Cells24 citations Open access
Semantic Scholar
Ultra-rapid selection of the N74D capsid inhibitor resistance mutation after 3 weeks on lenacapavir.
M. Wirden, Cécile Pouderoux, G. Peytavin, B. Abdi +8 more
2024Journal of Antimicrobial Chemotherapy22 citations
Semantic Scholar
Immune Reconstitution Inflammatory Syndrome Associated Kaposi Sarcoma
I. Poizot-Martin, S. Brégigeon, R. Palich, A. Marcelin +5 more
2022Cancers22 citations Open access
Semantic Scholar
Safety and tolerability of immune checkpoint inhibitors in people with HIV infection and cancer: insights from the national prospective real-world OncoVIHAC ANRS CO24 cohort study
L. Assoumou, R. Baldé, C. Katlama, B. Abbar +17 more
2024Journal for ImmunoTherapy of Cancer21 citations Open access
Semantic Scholar
Pre-COVID-19 Immunity to Common Cold Human Coronaviruses Induces a Recall-Type IgG Response to SARS-CoV-2 Antigens Without Cross-Neutralisation
M. Miyara, Melissa Saichi, D. Sterlin, François Anna +29 more
2022Frontiers in Immunology20 citations Open access
Semantic Scholar
Time to negative PCR conversion amongst high-risk patients with mild-to-moderate Omicron BA.1 and BA.2 COVID-19 treated with sotrovimab or nirmatrelvir
G. Martin-Blondel, A. Marcelin, C. Soulié, Sofia Kaisaridi +30 more
2022Clinical Microbiology and Infection19 citations Open access
Semantic Scholar
Outcome of very high-risk patients treated by Sotrovimab for mild-to-moderate COVID-19 Omicron, a prospective cohort study (the ANRS 0003S COCOPREV study)
G. Martin-Blondel, A. Marcelin, C. Soulié, Sofia Kaisaridi +10 more
2022Journal of Infection18 citations Open access
Semantic Scholar
Virologic Response to Dolutegravir Plus Lamivudine in People With Suppressed Human Immunodeficiency Virus Type 1 and Historical M184V/I: A Systematic Literature Review and Meta-analysis
Madhusudan Kabra, Tristan J. Barber, C. Allavena, A. Marcelin +17 more
2023Open Forum Infectious Diseases17 citations Open access
Semantic Scholar
CD30 as a therapeutic target in adult haematological malignancies: Where are we now?
M. Veyri, J. Spano, F. Le Bras, A. Marcelin +1 more
2023British Journal of Haematology15 citations Open access
Semantic Scholar
Sotrovimab therapy elicits antiviral activities against Omicron BQ.1.1 and XBB.1.5 in sera of immunocompromised patients
T. Bruel, Lou-Léna Vrignaud, F. Porrot, I. Staropoli +20 more
2023i Medicina15 citations Open access
Semantic Scholar
Intermittent Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment Maintains High Level of Viral Suppression in Virally Suppressed People Living with HIV
B. Sellem, B. Abdi, M. Lê, R. Tubiana +10 more
2023Journal of Personalized Medicine14 citations Open access
Semantic Scholar
Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings.
D. Armenia, M. Santoro, C. Charpentier, A. Bertoli +6 more
2023Journal of Antimicrobial Chemotherapy14 citations
Semantic Scholar
Recommendations on data sharing in HIV drug resistance research
S. Inzaule, M. Siedner, S. Little, Santiago Ávila-Ríos +42 more
2023PLoS Medicine12 citations Open access
Semantic Scholar
Nosocomial transmission clusters and lineage diversity characterized by SARS-CoV-2 genomes from two large hospitals in Paris, France, in 2020
V. Leducq, A. Jary, A. Bridier-Nahmias, Léna Daniel +9 more
2022Scientific Reports11 citations Open access
Semantic Scholar
Intranasally administrated fusion-inhibitory lipopeptides block SARS-CoV-2 infection in mice and enable long-term protective immunity
S. Mougari, Valérie Favède, Camilla Predella, O. Reynard +21 more
2025Communications Biology10 citations Open access
Semantic Scholar
High seroconversion rate and SARS-CoV-2 Delta neutralization in people with HIV vaccinated with BNT162b2
V. Pourcher, L. Belin, C. Soulié, M. Rosenzwajg +14 more
2022AIDS (London)10 citations Open access
Semantic Scholar
Emergent resistance-associated mutations at first- or second-line HIV-1 virologic failure with second-generation InSTIs in two- and three-drug regimens: the Virostar-1 study
A. Marcelin, C. Soulié, M. Wirden, G. Barrière +4 more
2024Journal of Antimicrobial Chemotherapy9 citations Open access
Semantic Scholar
Spike protein genetic evolution in patients at high-risk of severe COVID-19 treated by monoclonal antibodies.
V. Leducq, K. Zafilaza, A. Fauchois, Emna Ghidaoui +9 more
2023Journal of Infectious Diseases9 citations Open access
Semantic Scholar
Prevalence of HIV-1 Natural Polymorphisms and Integrase-Resistance-Associated Mutations in African Children
Djeneba B. Fofana, Houdou Diarra, Ibrehima Guindo, M. Savadogo +17 more
2023Viruses9 citations Open access
Semantic Scholar
The human gut microbiome and its metabolic pathway dynamics before and during HIV antiretroviral therapy
Oumar Dolo, Fousseini Coulibaly, A. M. Somboro, Shan Sun +14 more
2025Microbiology spectrum8 citations Open access
Semantic Scholar
Optimizing the Use of Cabotegravir Plus Rilpivirine Long-acting Therapy in HIV Care: Evidence, Implementation, and Unanswered Questions
A. Geretti, M. Boffito, S. Bonora, P. Braun +12 more
2025Open Forum Infectious Diseases8 citations Open access
Semantic Scholar
A new class of capsid-targeting inhibitors that specifically block HIV-1 nuclear import
Aude Boulay, Emmanuel Quevarec, I. Malet, Giuseppe Nicastro +10 more
2024EMBO Molecular Medicine8 citations Open access
Semantic Scholar
A New Topical Candidate in Acne Treatment: Characterization of the Meclozine Hydrochloride as an Anti-Inflammatory Compound from In Vitro to a Preliminary Clinical Study
P. Grange, G. Ollagnier, Laurianne Beauvais Remigereau, C. Nicco +4 more
2022Biomedicines8 citations Open access
Semantic Scholar
Incidence and Burden of Respiratory Syncytial Virus-Associated Hospitalizations Among People 65 and Older in France: A National Hospital Database Study
S. Marot, C. Demont, T. Cochérie, Miao Jiang +15 more
2025Open Forum Infectious Diseases7 citations Open access
Semantic Scholar
Use of genotypic HIV DNA testing: a DELPHI-type consensus
E. André-Garnier, L. Bocket, T. Bourlet, L. Hocqueloux +8 more
2024Journal of Antimicrobial Chemotherapy7 citations Open access
Semantic Scholar
The RT M184V resistance mutation clearance in the reservoir is mainly related to CD4 nadir and viral load zenith independently of therapeutic regimen type.
E. Teyssou, C. Soulié, A. Fauchois, R. Palich +8 more
2024Journal of Antimicrobial Chemotherapy7 citations Open access
Semantic Scholar
Three to four mRNA COVID‐19 vaccines in multiple sclerosis patients on immunosuppressive drugs: Seroconversion and variant neutralization
C. Louapre, L. Belin, S. Marot, A. Hippolyte +10 more
2023European Journal of Neurology7 citations Open access
Semantic Scholar
Phylodynamics of SARS-CoV-2 in France, Europe, and the world in 2020
R. Coppée, F. Blanquart, A. Jary, V. Leducq +11 more
2023eLife7 citations Open access
Semantic Scholar
Longitudinal analysis of lentiviral and retroviral chimeric antigen receptors' integration sites reveals distinct clonal evolutionary patterns
Vincent Guiraud, Jérôme-Alexandre Denis, Ghizlane Benhafoun, Erwan Ablin +10 more
2025British Journal of Haematology6 citations Open access
Semantic Scholar
Doravirine plus lamivudine two-drug regimen as maintenance antiretroviral therapy in people living with HIV: a French observational study.
P. Perfezou, N. Hall, J. Duthé, B. Abdi +7 more
2023Journal of Antimicrobial Chemotherapy6 citations Open access
Semantic Scholar
Higher levels of SARS-CoV-2 genetic variation in immunocompromised patients: a retrospective case-control study.
Romane Guilbaud, Anna-Maria Franco Yusti, V. Leducq, K. Zafilaza +27 more
2023Journal of Infectious Diseases6 citations Open access
Semantic Scholar
Identification of natural killer markers associated with fatal outcome in COVID-19 patients
N. Tarantino, E. Litvinova, A. Samri, C. Soulié +17 more
2023Frontiers in Cellular and Infection Microbiology6 citations Open access
Semantic Scholar
Is vaccine response to SARS-CoV-2 preserved after switching to anti-CD20 therapies in patients with multiple sclerosis or related disorders?
L. Jeantin, B. Abdi, C. Soulié, D. Sterlin +7 more
2023Journal of Neurology Neurosurgery & Psychiatry6 citations
Semantic Scholar
Antiviral activities of sotrovimab against BQ.1.1 and XBB.1.5 in sera of treated patients
T. Bruel, Lou-Léna Vrignaud, F. Porrot, I. Staropoli +20 more
2023medRxiv6 citations Open access
Semantic Scholar
SARS-CoV-2 Genomic Characteristics and Clinical Impact of SARS-CoV-2 Viral Diversity in Critically Ill COVID-19 Patients: A Prospective Multicenter Cohort Study
S. Fourati, E. Audureau, R. Arrestier, S. Marot +26 more
2022Viruses6 citations Open access
Semantic Scholar
Harnessing Redox Disruption to Treat Human Herpesvirus 8 (HHV-8) Related Malignancies
A. Gothland, A. Jary, P. Grange, V. Leducq +4 more
2022Antioxidants6 citations Open access
Semantic Scholar
Anti-SARS-CoV-2 glyco-humanized polyclonal antibody XAV-19: phase II/III randomized placebo-controlled trial shows acceleration to recovery for mild to moderate patients with COVID-19
Garyfallia Poulakou, P. Royer, N. Evgeniev, G. Evanno +6 more
2024Frontiers in Immunology5 citations Open access
Semantic Scholar
Similar Viral and Immune Characteristics of Kaposi Sarcoma in ART-treated People Living With HIV and Older Patients With Classic Kaposi Sarcoma
L. Royston, A. Jary, C. Berini, Tsoarello Mabanga +10 more
2024Open Forum Infectious Diseases5 citations Open access
Semantic Scholar
Clearance of archived integrase strand transfer inhibitors resistance mutations in people with virologically suppressed HIV infection
B. Abdi, R. Palich, S. Seang, A. Fauchois +12 more
2024JAC-Antimicrobial Resistance5 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Soulié×18
Invite
C. Soulié — researcher profile on SciRah
V. Cálvez×14
Invite
V. Cálvez — researcher profile on SciRah
S. Marot×12
Invite
S. Marot — researcher profile on SciRah
K. Zafilaza×12
Invite
K. Zafilaza — researcher profile on SciRah

×9

Invite

D. Descamps — researcher profile on SciRah

Invite

V. Leducq — researcher profile on SciRah

Invite

B. Abdi — researcher profile on SciRah

Invite

V. Pourcher — researcher profile on SciRah

Invite

A. Jary — researcher profile on SciRah

Invite

V. Calvez — researcher profile on SciRah

Invite

S. Burrel — researcher profile on SciRah

Invite

S. Sayon — researcher profile on SciRah